Funding for this research was provided by:
National Natural Science Foundation of China (81571583)
Text and Data Mining valid from 2018-11-08
Received: 3 April 2018
Revised: 1 September 2018
Accepted: 30 September 2018
First Online: 8 November 2018
Ethics approval and consent to participate
: All animal experiments were approved by Ethics Committee of the Affiliated Drum Tower Hospital of Nanjing University Medical School. This study was approved by the Ethics Committee at the Drum Tower Hospital of Nanjing University Medical School and registered at ExternalRef removed. (NTC00953485, Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren’s Syndrome, registered August 6, 2009, first participant enrolled on September 1, 2009). All patients gave consent to participate.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.